vs

Side-by-side financial comparison of BIOMERICA INC (BMRA) and Rigetti Computing, Inc. (RGTI). Click either name above to swap in a different company.

Rigetti Computing, Inc. is the larger business by last-quarter revenue ($1.9M vs $1.2M, roughly 1.5× BIOMERICA INC). BIOMERICA INC runs the higher net margin — -109.1% vs -974.7%, a 865.6% gap on every dollar of revenue. On growth, Rigetti Computing, Inc. posted the faster year-over-year revenue change (-17.9% vs -26.0%). Over the past eight quarters, BIOMERICA INC's revenue compounded faster (-12.1% CAGR vs -21.8%).

Biomerica Inc. is a global medical technology company that develops, manufactures and markets diagnostic test kits and related medical products. Its portfolio covers gastrointestinal conditions, infectious diseases, food intolerances and point-of-care testing solutions, serving clinical labs, healthcare providers and retail healthcare segments across North America, Europe and Asia.

Rigetti Computing, Inc. is a Berkeley, California-based developer of superconducting quantum integrated circuits used for quantum computers. Rigetti also develops a cloud platform called Forest that enables programmers to write quantum algorithms.

BMRA vs RGTI — Head-to-Head

Bigger by revenue
RGTI
RGTI
1.5× larger
RGTI
$1.9M
$1.2M
BMRA
Growing faster (revenue YoY)
RGTI
RGTI
+8.2% gap
RGTI
-17.9%
-26.0%
BMRA
Higher net margin
BMRA
BMRA
865.6% more per $
BMRA
-109.1%
-974.7%
RGTI
Faster 2-yr revenue CAGR
BMRA
BMRA
Annualised
BMRA
-12.1%
-21.8%
RGTI

Income Statement — Q2 FY2026 vs Q4 FY2025

Metric
BMRA
BMRA
RGTI
RGTI
Revenue
$1.2M
$1.9M
Net Profit
$-1.3M
$-18.2M
Gross Margin
4.2%
34.9%
Operating Margin
-113.5%
-1209.7%
Net Margin
-109.1%
-974.7%
Revenue YoY
-26.0%
-17.9%
Net Profit YoY
-38.9%
88.1%
EPS (diluted)
$-0.45
$-0.08

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BMRA
BMRA
RGTI
RGTI
Q4 25
$1.2M
$1.9M
Q3 25
$1.4M
$1.9M
Q2 25
$1.8M
Q1 25
$1.1M
$1.5M
Q4 24
$1.6M
$2.3M
Q3 24
$1.8M
$2.4M
Q2 24
$1.1M
$3.1M
Q1 24
$1.0M
$3.1M
Net Profit
BMRA
BMRA
RGTI
RGTI
Q4 25
$-1.3M
$-18.2M
Q3 25
$2.0K
$-201.0M
Q2 25
$-39.7M
Q1 25
$-1.2M
$42.6M
Q4 24
$-950.0K
$-153.0M
Q3 24
$-1.3M
$-14.8M
Q2 24
$-1.4M
$-12.4M
Q1 24
$-1.9M
$-20.8M
Gross Margin
BMRA
BMRA
RGTI
RGTI
Q4 25
4.2%
34.9%
Q3 25
30.7%
20.7%
Q2 25
31.4%
Q1 25
1.7%
30.0%
Q4 24
26.7%
44.1%
Q3 24
16.0%
50.6%
Q2 24
2.1%
64.5%
Q1 24
-14.7%
49.1%
Operating Margin
BMRA
BMRA
RGTI
RGTI
Q4 25
-113.5%
-1209.7%
Q3 25
-81.0%
-1055.4%
Q2 25
-1103.9%
Q1 25
-108.1%
-1469.6%
Q4 24
-60.7%
-813.3%
Q3 24
-75.7%
-729.4%
Q2 24
-136.6%
-521.2%
Q1 24
-196.7%
-543.4%
Net Margin
BMRA
BMRA
RGTI
RGTI
Q4 25
-109.1%
-974.7%
Q3 25
0.1%
-10321.9%
Q2 25
-2201.8%
Q1 25
-103.9%
2895.3%
Q4 24
-58.1%
-6726.5%
Q3 24
-72.8%
-623.8%
Q2 24
-127.1%
-402.5%
Q1 24
-188.6%
-680.6%
EPS (diluted)
BMRA
BMRA
RGTI
RGTI
Q4 25
$-0.45
$-0.08
Q3 25
$0.00
$-0.62
Q2 25
$-0.13
Q1 25
$-0.48
$0.13
Q4 24
$-0.06
$-0.80
Q3 24
$-0.63
$-0.08
Q2 24
$-2.57
$-0.07
Q1 24
$-0.11
$-0.14

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BMRA
BMRA
RGTI
RGTI
Cash + ST InvestmentsLiquidity on hand
$2.5M
$44.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$4.4M
$546.2M
Total Assets
$6.0M
$666.6M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BMRA
BMRA
RGTI
RGTI
Q4 25
$2.5M
$44.9M
Q3 25
$3.1M
$26.1M
Q2 25
$57.2M
Q1 25
$3.1M
$37.2M
Q4 24
$2.4M
$67.7M
Q3 24
$2.8M
$20.3M
Q2 24
$4.2M
$20.7M
Q1 24
$5.3M
$35.1M
Stockholders' Equity
BMRA
BMRA
RGTI
RGTI
Q4 25
$4.4M
$546.2M
Q3 25
$5.2M
$371.8M
Q2 25
$553.3M
Q1 25
$5.5M
$207.1M
Q4 24
$5.1M
$126.6M
Q3 24
$5.3M
$122.8M
Q2 24
$6.6M
$122.2M
Q1 24
$7.8M
$115.6M
Total Assets
BMRA
BMRA
RGTI
RGTI
Q4 25
$6.0M
$666.6M
Q3 25
$6.9M
$630.3M
Q2 25
$636.7M
Q1 25
$7.4M
$269.1M
Q4 24
$7.3M
$284.8M
Q3 24
$7.9M
$157.3M
Q2 24
$9.3M
$162.4M
Q1 24
$10.3M
$162.1M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BMRA
BMRA
RGTI
RGTI
Operating Cash FlowLast quarter
$-991.0K
$-14.9M
Free Cash FlowOCF − Capex
$-19.5M
FCF MarginFCF / Revenue
-1042.5%
Capex IntensityCapex / Revenue
244.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-77.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BMRA
BMRA
RGTI
RGTI
Q4 25
$-991.0K
$-14.9M
Q3 25
$-268.0K
$-13.8M
Q2 25
$-16.2M
Q1 25
$-1.0M
$-13.7M
Q4 24
$-791.0K
$-8.5M
Q3 24
$-1.3M
$-15.4M
Q2 24
$-1.0M
$-13.5M
Q1 24
$-1.8M
$-13.1M
Free Cash Flow
BMRA
BMRA
RGTI
RGTI
Q4 25
$-19.5M
Q3 25
$-19.7M
Q2 25
$-21.8M
Q1 25
$-16.2M
Q4 24
$-9.8M
Q3 24
$-17.7M
Q2 24
$-1.1M
$-15.6M
Q1 24
$-18.6M
FCF Margin
BMRA
BMRA
RGTI
RGTI
Q4 25
-1042.5%
Q3 25
-1012.4%
Q2 25
-1212.4%
Q1 25
-1100.4%
Q4 24
-432.1%
Q3 24
-744.5%
Q2 24
-95.5%
-504.3%
Q1 24
-610.5%
Capex Intensity
BMRA
BMRA
RGTI
RGTI
Q4 25
244.8%
Q3 25
302.5%
Q2 25
314.7%
Q1 25
173.0%
Q4 24
56.4%
Q3 24
95.8%
Q2 24
2.1%
66.3%
Q1 24
0.0%
180.0%
Cash Conversion
BMRA
BMRA
RGTI
RGTI
Q4 25
Q3 25
-134.00×
Q2 25
Q1 25
-0.32×
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BMRA
BMRA

Segment breakdown not available.

RGTI
RGTI

Collaborative Research And Other Professional Services$1.7M93%
Other$131.0K7%

Related Comparisons